Candel Therapeutics (CADL) Non-Current Assets: 2020-2023
Historic Non-Current Assets for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $5.0 million.
- Candel Therapeutics' Non-Current Assets fell 16.46% to $5.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $5.0 million, marking a year-over-year decrease of 16.46%. This contributed to the annual value of $5.7 million for FY2022, which is 34.88% up from last year.
- Per Candel Therapeutics' latest filing, its Non-Current Assets stood at $5.0 million for Q3 2023, which was down 7.22% from $5.3 million recorded in Q2 2023.
- Candel Therapeutics' Non-Current Assets' 5-year high stood at $6.3 million during Q2 2021, with a 5-year trough of $3.1 million in Q4 2020.
- Over the past 3 years, Candel Therapeutics' median Non-Current Assets value was $5.6 million (recorded in 2022), while the average stood at $5.5 million.
- Per our database at Business Quant, Candel Therapeutics' Non-Current Assets surged by 35.84% in 2021 and then fell by 16.46% in 2023.
- Over the past 4 years, Candel Therapeutics' Non-Current Assets (Quarterly) stood at $3.1 million in 2020, then spiked by 35.84% to $4.3 million in 2021, then skyrocketed by 34.88% to $5.7 million in 2022, then dropped by 16.46% to $5.0 million in 2023.
- Its last three reported values are $5.0 million in Q3 2023, $5.3 million for Q2 2023, and $5.4 million during Q1 2023.